DOMAIN PARTERS VII L P

CIK 000137415011 companiesPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001374150

Recent Transactions

50 trades

Purchase
Vyome Holdings, Inc$HIND
Warrants to Purchase Common Stock
2019-08-06$4.00/sh+187,500→ 187,500 total
Purchase
Vyome Holdings, Inc$HIND
Common Stock
2019-08-06$4.00/sh+250,000→ 813,433 total
Purchase
Vyome Holdings, Inc$HIND
Common Stock
2018-08-23$1.82/sh+1,648,359→ 5,634,329 total
Disposition from Tender
Tobira Therapeutics, Inc.
Common Stock
2016-11-01$28.35/sh−3,553,322→ 0 total
Conversion
Vyome Holdings, Inc$HIND
Series B Preferred Stock
2016-10-12−1,206,836→ 0 total
Conversion
Vyome Holdings, Inc$HIND
Series C Preferred Stock
2016-10-12−836,722→ 0 total
Conversion
Vyome Holdings, Inc$HIND
Series D Preferred Stock
2016-10-12−597,207→ 0 total
Conversion
Vyome Holdings, Inc$HIND
Series E Preferred Stock
2016-10-12−482,326→ 0 total
Conversion
Vyome Holdings, Inc$HIND
Common Stock
2016-10-12+3,985,970→ 3,985,970 total
Conversion
Vyome Holdings, Inc$HIND
Series A Preferred Stock
2016-10-12−649,835→ 0 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2016-05-26$4.70/sh−344,120→ 606,283 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2016-04-27$5.02/sh−3,603→ 950,403 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2016-04-25$5.20/sh−1,492→ 954,006 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2016-04-20$5.29/sh−4,424→ 955,498 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2016-04-19$5.36/sh−37,054→ 959,922 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2016-04-11$5.22/sh−4,348→ 996,976 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2016-04-08$5.35/sh−14,554→ 1,001,324 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2016-04-07$5.26/sh−27,781→ 1,015,878 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2016-04-06$5.22/sh−8,669→ 1,043,659 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2015-08-18$7.02/sh−11,836→ 1,052,328 total
Purchase
Tobira Therapeutics, Inc.
Common Stock
2015-05-04$10.62/sh+277,777→ 3,553,322 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2015-04-16$7.07/sh−32,411→ 1,064,164 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2015-04-15$7.58/sh−7,920→ 1,096,575 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2015-04-14$7.78/sh−9,832→ 1,104,495 total
Other
Esperion Therapeutics, Inc.$ESPR
Common Stock
2015-03-20−350,000→ 2,216,935 total
Exercise/Conversion
Evofem Biosciences, Inc.$EVFM
Series B-2 Preferred Stock Warrant (Right to Buy)
2014-11-25−92,105→ 0 total
Tax Payment
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25$14.00/sh−56,185→ 2,956,984 total
Purchase
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25$14.00/sh+70,000→ 3,091,642 total
Conversion
Evofem Biosciences, Inc.$EVFM
Series B-2 Preferred Stock
2014-11-25−2,164,305→ 0 total
Conversion
Evofem Biosciences, Inc.$EVFM
Series B Preferred Stock
2014-11-25−6,111,968→ 0 total
Purchase
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25$14.00/sh+70,000→ 3,091,643 total
Exercise/Conversion
Evofem Biosciences, Inc.$EVFM
Series C Preferred Stock Warrant (Right to Buy)
2014-11-25−165,790→ 0 total
Exercise/Conversion
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25$8.54/sh+92,105→ 3,013,169 total
Tax Payment
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25$14.00/sh−56,185→ 2,956,985 total
Conversion
Evofem Biosciences, Inc.$EVFM
Series C Preferred Stock
2014-11-25−7,252,144→ 0 total
Exercise/Conversion
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25$8.54/sh+165,790→ 3,122,774 total
Tax Payment
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25$14.00/sh−101,132→ 3,021,643 total
Exercise/Conversion
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25$8.54/sh+92,105→ 3,013,170 total
Conversion
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25+2,921,064→ 2,921,064 total
Conversion
Evofem Biosciences, Inc.$EVFM
Series B-2 Preferred Stock
2014-11-25−2,164,305→ 0 total
Exercise/Conversion
Evofem Biosciences, Inc.$EVFM
Series C Preferred Stock Warrant (Right to Buy)
2014-11-25−165,790→ 0 total
Conversion
Evofem Biosciences, Inc.$EVFM
Series A Preferred Stock
2014-11-25−737,422→ 0 total
Tax Payment
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25$14.00/sh−101,132→ 3,021,642 total
Conversion
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25+2,921,065→ 2,921,065 total
Exercise/Conversion
Evofem Biosciences, Inc.$EVFM
Series B-2 Preferred Stock Warrant (Right to Buy)
2014-11-25−92,105→ 0 total
Exercise/Conversion
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25$8.54/sh+165,790→ 3,122,775 total
Conversion
Evofem Biosciences, Inc.$EVFM
Series A Preferred Stock
2014-11-25−737,422→ 0 total
Conversion
Evofem Biosciences, Inc.$EVFM
Series B Preferred Stock
2014-11-25−6,111,968→ 0 total
Conversion
Evofem Biosciences, Inc.$EVFM
Series C Preferred Stock
2014-11-25−7,252,144→ 0 total
Purchase
Esperion Therapeutics, Inc.$ESPR
Common Stock
2014-10-21$20.00/sh+500,000→ 2,566,935 total

DOMAIN PARTERS VII L P

Recent Transactions

Companies

Recent Filings

Address